Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - temozolomide, quantity: 5 mg - capsule, hard - excipient ingredients: indigo carmine; colloidal anhydrous silica; iron oxide yellow; stearic acid; titanium dioxide; lactose; purified water; gelatin; sodium starch glycollate; tartaric acid; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,treatment of recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as a first-line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 180 mg - capsule - excipient ingredients: purified water; purified talc; gelatin; silicon dioxide; lactose; sodium starch glycollate; titanium dioxide; iron oxide red; tartaric acid; stearic acid; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,? patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,? recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 5 mg - capsule - excipient ingredients: purified water; purified talc; sodium starch glycollate; titanium dioxide; gelatin; iron oxide yellow; stearic acid; indigo carmine; lactose; silicon dioxide; tartaric acid; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,? patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,? recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 100 mg - capsule - excipient ingredients: lactose; purified talc; titanium dioxide; iron oxide red; gelatin; tartaric acid; purified water; sodium starch glycollate; stearic acid; silicon dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,? patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,? recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 20 mg - capsule - excipient ingredients: titanium dioxide; sodium starch glycollate; lactose; purified water; iron oxide yellow; gelatin; purified talc; silicon dioxide; tartaric acid; stearic acid; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,? patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,? recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 250 mg - capsule - excipient ingredients: purified water; stearic acid; gelatin; tartaric acid; lactose; sodium starch glycollate; silicon dioxide; titanium dioxide; purified talc; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,? patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,? recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - temozolomide, quantity: 140 mg - capsule - excipient ingredients: gelatin; tartaric acid; purified talc; lactose; purified water; indigo carmine; stearic acid; titanium dioxide; sodium starch glycollate; silicon dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - temozolomide is indicated for the treatment of:,? patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.,? recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy.,temozolomide is also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

United States - English - NLM (National Library of Medicine)

idt australia limited - temozolomide (unii: yf1k15m17y) (temozolomide - unii:yf1k15m17y) - temozolomide 5 mg

United States - English - NLM (National Library of Medicine)

lotus pharmaceutical co., ltd.nantou plant - temozolomide (unii: yf1k15m17y) (temozolomide - unii:yf1k15m17y) - temozolomide 5 mg

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - temozolomide (unii: yf1k15m17y) (temozolomide - unii:yf1k15m17y) - temozolomide 5 mg